PGH1, the precursor for the anti-inflammatory prostaglandins of the 1-series, is a potent activator of the pro-inflammatory receptor CRTH2/DP2.
Prostaglandin H(1) (PGH(1)) is the cyclo-oxygenase metabolite of dihomo-γ-linolenic acid (DGLA) and the precursor for the 1-series of prostaglandins which are often viewed as "anti-inflammatory". Herein we present evidence that PGH(1) is a potent activator of the pro-inflammatory PGD(2) re...
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
2012
|
| _version_ | 1797068886823141376 |
|---|---|
| author | Schröder, R Xue, L Konya, V Martini, L Kampitsch, N Whistler, J Ulven, T Heinemann, A Pettipher, R Kostenis, E |
| author_facet | Schröder, R Xue, L Konya, V Martini, L Kampitsch, N Whistler, J Ulven, T Heinemann, A Pettipher, R Kostenis, E |
| author_sort | Schröder, R |
| collection | OXFORD |
| description | Prostaglandin H(1) (PGH(1)) is the cyclo-oxygenase metabolite of dihomo-γ-linolenic acid (DGLA) and the precursor for the 1-series of prostaglandins which are often viewed as "anti-inflammatory". Herein we present evidence that PGH(1) is a potent activator of the pro-inflammatory PGD(2) receptor CRTH2, an attractive therapeutic target to treat allergic diseases such as asthma and atopic dermatitis. Non-invasive, real time dynamic mass redistribution analysis of living human CRTH2 transfectants and Ca(2+) flux studies reveal that PGH(1) activates CRTH2 as PGH(2), PGD(2) or PGD(1) do. The PGH(1) precursor DGLA and the other PGH(1) metabolites did not display such effect. PGH(1) specifically internalizes CRTH2 in stable CRTH2 transfectants as assessed by antibody feeding assays. Physiological relevance of CRTH2 ligation by PGH(1) is demonstrated in several primary human hematopoietic lineages, which endogenously express CRTH2: PGH(1) mediates migration of and Ca(2+) flux in Th2 lymphocytes, shape change of eosinophils, and their adhesion to human pulmonary microvascular endothelial cells under physiological flow conditions. All these effects are abrogated in the presence of the CRTH2 specific antagonist TM30089. Together, our results identify PGH(1) as an important lipid intermediate and novel CRTH2 agonist which may trigger CRTH2 activation in vivo in the absence of functional prostaglandin D synthase. |
| first_indexed | 2024-03-06T22:16:27Z |
| format | Journal article |
| id | oxford-uuid:53896895-2431-4217-abd9-ae8c83727dde |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-06T22:16:27Z |
| publishDate | 2012 |
| record_format | dspace |
| spelling | oxford-uuid:53896895-2431-4217-abd9-ae8c83727dde2022-03-26T16:32:20ZPGH1, the precursor for the anti-inflammatory prostaglandins of the 1-series, is a potent activator of the pro-inflammatory receptor CRTH2/DP2.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:53896895-2431-4217-abd9-ae8c83727ddeEnglishSymplectic Elements at Oxford2012Schröder, RXue, LKonya, VMartini, LKampitsch, NWhistler, JUlven, THeinemann, APettipher, RKostenis, EProstaglandin H(1) (PGH(1)) is the cyclo-oxygenase metabolite of dihomo-γ-linolenic acid (DGLA) and the precursor for the 1-series of prostaglandins which are often viewed as "anti-inflammatory". Herein we present evidence that PGH(1) is a potent activator of the pro-inflammatory PGD(2) receptor CRTH2, an attractive therapeutic target to treat allergic diseases such as asthma and atopic dermatitis. Non-invasive, real time dynamic mass redistribution analysis of living human CRTH2 transfectants and Ca(2+) flux studies reveal that PGH(1) activates CRTH2 as PGH(2), PGD(2) or PGD(1) do. The PGH(1) precursor DGLA and the other PGH(1) metabolites did not display such effect. PGH(1) specifically internalizes CRTH2 in stable CRTH2 transfectants as assessed by antibody feeding assays. Physiological relevance of CRTH2 ligation by PGH(1) is demonstrated in several primary human hematopoietic lineages, which endogenously express CRTH2: PGH(1) mediates migration of and Ca(2+) flux in Th2 lymphocytes, shape change of eosinophils, and their adhesion to human pulmonary microvascular endothelial cells under physiological flow conditions. All these effects are abrogated in the presence of the CRTH2 specific antagonist TM30089. Together, our results identify PGH(1) as an important lipid intermediate and novel CRTH2 agonist which may trigger CRTH2 activation in vivo in the absence of functional prostaglandin D synthase. |
| spellingShingle | Schröder, R Xue, L Konya, V Martini, L Kampitsch, N Whistler, J Ulven, T Heinemann, A Pettipher, R Kostenis, E PGH1, the precursor for the anti-inflammatory prostaglandins of the 1-series, is a potent activator of the pro-inflammatory receptor CRTH2/DP2. |
| title | PGH1, the precursor for the anti-inflammatory prostaglandins of the 1-series, is a potent activator of the pro-inflammatory receptor CRTH2/DP2. |
| title_full | PGH1, the precursor for the anti-inflammatory prostaglandins of the 1-series, is a potent activator of the pro-inflammatory receptor CRTH2/DP2. |
| title_fullStr | PGH1, the precursor for the anti-inflammatory prostaglandins of the 1-series, is a potent activator of the pro-inflammatory receptor CRTH2/DP2. |
| title_full_unstemmed | PGH1, the precursor for the anti-inflammatory prostaglandins of the 1-series, is a potent activator of the pro-inflammatory receptor CRTH2/DP2. |
| title_short | PGH1, the precursor for the anti-inflammatory prostaglandins of the 1-series, is a potent activator of the pro-inflammatory receptor CRTH2/DP2. |
| title_sort | pgh1 the precursor for the anti inflammatory prostaglandins of the 1 series is a potent activator of the pro inflammatory receptor crth2 dp2 |
| work_keys_str_mv | AT schroderr pgh1theprecursorfortheantiinflammatoryprostaglandinsofthe1seriesisapotentactivatoroftheproinflammatoryreceptorcrth2dp2 AT xuel pgh1theprecursorfortheantiinflammatoryprostaglandinsofthe1seriesisapotentactivatoroftheproinflammatoryreceptorcrth2dp2 AT konyav pgh1theprecursorfortheantiinflammatoryprostaglandinsofthe1seriesisapotentactivatoroftheproinflammatoryreceptorcrth2dp2 AT martinil pgh1theprecursorfortheantiinflammatoryprostaglandinsofthe1seriesisapotentactivatoroftheproinflammatoryreceptorcrth2dp2 AT kampitschn pgh1theprecursorfortheantiinflammatoryprostaglandinsofthe1seriesisapotentactivatoroftheproinflammatoryreceptorcrth2dp2 AT whistlerj pgh1theprecursorfortheantiinflammatoryprostaglandinsofthe1seriesisapotentactivatoroftheproinflammatoryreceptorcrth2dp2 AT ulvent pgh1theprecursorfortheantiinflammatoryprostaglandinsofthe1seriesisapotentactivatoroftheproinflammatoryreceptorcrth2dp2 AT heinemanna pgh1theprecursorfortheantiinflammatoryprostaglandinsofthe1seriesisapotentactivatoroftheproinflammatoryreceptorcrth2dp2 AT pettipherr pgh1theprecursorfortheantiinflammatoryprostaglandinsofthe1seriesisapotentactivatoroftheproinflammatoryreceptorcrth2dp2 AT kostenise pgh1theprecursorfortheantiinflammatoryprostaglandinsofthe1seriesisapotentactivatoroftheproinflammatoryreceptorcrth2dp2 |